Ireland: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Ireland

The Irish market for other medicaments for therapeutic or prophylactic uses contracted to $X in 2022, with a decrease of X% against the previous year. Overall, consumption, however, saw a resilient expansion. Over the period under review, the market attained the peak level at $X in 2019; however, from 2020 to 2022, consumption failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Ireland

In value terms, production of other medicaments for therapeutic or prophylactic uses rose modestly to $X in 2022 estimated in export price. Over the period under review, production, however, enjoyed a resilient expansion. The most prominent rate of growth was recorded in 2018 when the production volume increased by X% against the previous year. Over the period under review, production of reached the peak level at $X in 2020; however, from 2021 to 2022, production stood at a somewhat lower figure.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Ireland

Exports of other medicaments for therapeutic or prophylactic uses from Ireland surged to X tons in 2022, picking up by X% on the year before. In general, exports showed a relatively flat trend pattern. The pace of growth was the most pronounced in 2016 with an increase of X%. As a result, the exports attained the peak of X tons. From 2017 to 2022, the growth of the exports of remained at a somewhat lower figure.

In value terms, exports of other medicaments for therapeutic or prophylactic uses soared to $X in 2022. Over the period under review, exports, however, saw a abrupt decrease. The most prominent rate of growth was recorded in 2016 with an increase of X%. The exports peaked at $X in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

Exports by Country

France (X tons), Panama (X tons) and the Netherlands (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Ireland, together accounting for X% of total exports. Germany, the UK, Hungary, Egypt, Vietnam, Slovenia, Algeria, Canada, Serbia and Australia lagged somewhat behind, together comprising a further X%.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by Slovenia (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, the Netherlands ($X) emerged as the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Ireland, comprising X% of total exports. The second position in the ranking was held by France ($X), with a X% share of total exports. It was followed by Canada, with a X% share.

From 2012 to 2022, the average annual growth rate of value to the Netherlands amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: France (X% per year) and Canada (X% per year).

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, surging by X% against the previous year. In general, the export price, however, showed a deep downturn. The pace of growth was the most pronounced in 2019 when the average export price increased by X%. The export price peaked at $X per ton in 2014; however, from 2015 to 2022, the export prices failed to regain momentum.

There were significant differences in the average prices for the major overseas markets. In 2022, amid the top suppliers, the country with the highest price was the Netherlands ($X per ton), while the average price for exports to Slovenia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Canada (X%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Ireland

In 2022, supplies from abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second consecutive year after two years of decline. Overall, imports continue to indicate a mild expansion. The most prominent rate of growth was recorded in 2018 with an increase of X% against the previous year. As a result, imports attained the peak of X tons. From 2019 to 2022, the growth of imports of remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses rose notably to $X in 2022. Over the period under review, imports enjoyed a resilient increase. The most prominent rate of growth was recorded in 2018 with an increase of X% against the previous year. As a result, imports reached the peak of $X. From 2019 to 2022, the growth of imports of remained at a lower figure.

Imports by Country

In 2022, the United States (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to Ireland, with a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from the United States exceeded the figures recorded by the second-largest supplier, the Netherlands (X tons), fourfold. The third position in this ranking was taken by Belgium (X tons), with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from the United States amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: the Netherlands (X% per year) and Belgium (X% per year).

In value terms, the United States ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Ireland, comprising X% of total imports. The second position in the ranking was taken by Germany ($X), with a X% share of total imports. It was followed by Belgium, with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from the United States totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and Belgium (X% per year).

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, which is down by X% against the previous year. Overall, the import price, however, posted strong growth. The pace of growth was the most pronounced in 2018 when the average import price increased by X% against the previous year. As a result, import price reached the peak level of $X,939 per ton. From 2019 to 2022, the average import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Germany ($X,382 per ton), while the price for Denmark ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :